# FDA 145 - QuVa Pharma, Inc. - March 24, 2017

Source: https://www.keypedia.com/records/145/quva-pharma-inc/10ece0b1-0003-41fb-b907-d82c82da8b1b

> FDA 145 for QuVa Pharma, Inc. on March 24, 2017. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 145
- Company Name: QuVa Pharma, Inc.
- Inspection Date: 2017-03-24
- Product Type: Drugs

## Related Documents

- [483 - 2017-06-02](https://www.keypedia.com/records/483/quva-pharma-inc/1e39698c-7d20-4ed8-ae3a-29f14b507519)
- [483 - 2019-03-14](https://www.keypedia.com/records/483/quva-pharma-inc/ac997419-c9b0-4f1b-9875-97a2b70ddc77)
- [483 - 2019-05-31](https://www.keypedia.com/records/483/quva-pharma-inc/8cd7d039-95c1-4202-b52c-748d3117bb36)
- [483 - 2017-11-30](https://www.keypedia.com/records/483/quva-pharma-inc/db7a8ffe-e43a-4fef-be20-cac0f6d0f13f)
- [483 - 2019-04-23](https://www.keypedia.com/records/483/quva-pharma-inc/18f5b923-5e6c-4138-ae7b-8b6483eaa65e)

## Related Officers

- [Special Projects Team Lead](https://www.keypedia.com/people/jason-schilling/ff613660-d7fa-4025-9840-c837841dec75)

Company: https://www.keypedia.com/companies/quva-pharma-inc/1852735f-efbc-4896-9ba0-465f07d479e6